SP Elixir (OPC) Private Limited

Jaknat (Tofacitinib) Tablets contain tofacitinib, an Janus kinase (JAK) inhibitor used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and alopecia areata.

Tofacitinib works by inhibiting JAK enzymes, which are involved in the signaling pathways that contribute to the inflammatory process in autoimmune diseases. By blocking these enzymes, Jaknat helps to reduce inflammation, decrease symptoms, and prevent further damage to joints or tissues affected by these conditions.

It is typically taken orally once or twice daily, depending on the condition being treated. Regular monitoring is necessary due to potential side effects, such as infections, liver enzyme abnormalities, and blood cell count changes. Your healthcare provider will guide you on proper usage and monitoring during treatment.